$76.25
N/A
Last update: Oct 2, 10:31 AM

Get the latest news on BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG performance